Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL000957

Drug Information
Synonyms[(3R)-1-azabicyclo[2.2.2]octan-3-yl] (2R)-2-(hydroxymethyl)-4-methylsulfinyl-2-phenylbutanoate; CID3035836; CID6918246; UK-112166; CID9690123; UNII-3W7L15V40W; AC1OCF7F; CID9554797; AC1MI026; UK-112,166; [(3R)-1-azabicyclo[2.2.2]octan-3-yl] (2S)-2-(hydroxymethyl)-4-methylsulfinyl-2-phenylbutanoate; Revatropate; Benzenacetic acid, alpha-(hydroxymethyl)-alpha-(2-(methylsulfinyl)ethyl)-, 1-azabicyclo(2.2.2)oct-3-yl ester, (3R-(3R*(S*(R*))))-; (3R-(3R*(S*(R*))))-1-Azabicyclo(2.2.2)oct-3-yl alpha-(hydroxymethyl)-alpha-(2-(methylsulfinyl)ethyl)benzenacetate; UK-112166-04; 149926-91-0    
IndicationChronic obstructive pulmonary diseaseDiscontinued in Phase I    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
CAS NumberCAS 149926-91-0
PubChem Compound IDCID 9690123.    
PubChem Substance IDSID 12014788.    
TargetMuscarinic acetylcholine receptor M1Antagonist[1]
Muscarinic acetylcholine receptor M1Multitarget[1]
Muscarinic acetylcholine receptor M3Antagonist[1]
Muscarinic acetylcholine receptor M3Multitarget[1]
Ref 1Emerging drugs for the treatment of chronic obstructive pulmonary disease. Expert Opin Emerg Drugs. 2006 May;11(2):275-91. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543